The funds will advance Genespire’s gene therapy for methylmalonic acidemia, a group of rare metabolic disorders, to Phase ...

The tracker, currently available via a pilot scheme, could save pharmacists hours by reducing patient queries.

This article explores the strategies that fill finish CDMOs use to effectively manage temperature-sensitive drug products ...

The epigenetic drugs space has witnessed a two-fold increase in Series A venture funding, with total deal value increasing to ...

Bavarian Nordic has received a $63m US contract to produce bulk product and final freeze-dried doses of the JYNNEOS ...

Generate:Biomedicines and Novartis have partnered for the discovery and development of protein therapeutics in multiple ...

Some counterfeits contain bacteria and have high impurity levels or different chemical structures to Lilly's FDA-approved ...

AllazoHealth has introduced AI-enabled dynamic modular content to enhance initiation and adherence to medications.

Eli Lilly has received approval in Japan for Kisunla (donanemab-azbt) to treat early symptomatic Alzheimer's disease.

Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.